Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)

by | Aug 26, 2026 | Clinical Trials

​ Conditions: Colorectal Cancer Interventions: Drug: Petosemtamab; Drug: Cetuximab; Drug: Bevacizumab; Drug: 5-FU; Drug: Leucovorin (Calcium Folinate); Drug: Oxaliplatin; Drug: Irinotecan Sponsors: Genmab Recruiting Conditions: Colorectal Cancer Interventions: Drug:...

ABCSG R07 Rectal Cancer Registry

by | Aug 26, 2026 | Clinical Trials

​ Conditions: Rectal Cancer; Adenocarcinoma of Rectum Sponsors: Austrian Breast & Colorectal Cancer Study Group; GlaxoSmithKline Not yet recruiting Conditions: Rectal Cancer; Adenocarcinoma of Rectum Sponsors: Austrian Breast & Colorectal Cancer Study Group;...

Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial

by | Aug 25, 2026 | Clinical Trials

​ Conditions: Locally Advanced Oral Cavity Squamous Cell Carcinoma; Locally Recurrent Oral Cavity Squamous Cell Carcinoma; Oral Cavity Squamous Cell Carcinoma Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Computed...